Correlation Between Citigroup and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Citigroup and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Citigroup and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Citigroup and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Takeda Pharmaceutical.

Diversification Opportunities for Citigroup and Takeda Pharmaceutical

-0.65

Correlation Coefficient

Citigroup  Takeda Pharmaceutical

Excellent diversification

The 3 months correlation between Citigroup and Takeda is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Citigroup i.e., Citigroup and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Citigroup and Takeda Pharmaceutical

Taking into account the 90-day investment horizon Citigroup is expected to generate 0.44 times more return on investment than Takeda Pharmaceutical. However, Citigroup is 2.29 times less risky than Takeda Pharmaceutical. It trades about 0.08 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.0 per unit of risk. If you would invest  4,558  in Citigroup on October 3, 2024 and sell it today you would earn a total of  2,481  from holding Citigroup or generate 54.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	77.55%
Values	Daily Returns

Citigroup  vs.  Takeda Pharmaceutical Co

Citigroup

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Citigroup exhibited solid returns over the last few months and may actually be approaching a breakup point.

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Citigroup and Takeda Pharmaceutical

The main advantage of trading using opposite Citigroup and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind Citigroup and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.